Skip to main navigation Skip to search Skip to main content

Pharmacogenomics of Glatiramer Acetate: Genetic Basis of Responsiveness to Glatiramer Acetate in Multiple Sclerosis Patients

Project: Research

Project Details

StatusFinished
Effective start/end date08/16/02 → 06/12/03

Funding

  • Teva Neuroscience Inc: $1,816.46